Valuation: Inhalation Sciences Sweden AB

Market Cap 7.4M 782K 669K 626K 573K 1.08M 74.81M 1.09M 2.88M 37.55M 2.94M 2.87M 125M P/E 2024
-12.8x
P/E 2025 -12.4x
Enterprise Value 4.57M 483K 413K 386K 354K 665K 46.18M 673K 1.78M 23.18M 1.81M 1.77M 77.3M EV / Sales 2024
5.6x
EV / Sales 2025 55x
Free-Float
94.25%
Yield 2024 *
-
Yield 2025 -
1 day-6.47%
1 week-3.67%
Current month-19.72%
1 month-33.41%
3 months-45.47%
6 months-41.73%
Current year-96.67%
1 week 0.13
Extreme 0.1315
0.16
1 month 0.13
Extreme 0.1315
0.24
Current year 0.13
Extreme 0.1315
0.58
1 year 0.13
Extreme 0.1315
0.58
3 years 0.13
Extreme 0.1315
4.99
5 years 0.13
Extreme 0.1315
11.3
10 years 0.13
Extreme 0.1315
15.48
Manager TitleAgeSince
Chief Executive Officer - 2019-09-15
Chief Tech/Sci/R&D Officer - 2004-12-31
Corporate Officer/Principal - 2025-06-01
Director TitleAgeSince
Director/Board Member - 2004-12-31
Director/Board Member - 2022-08-31
Director/Board Member - 2024-08-31
Change 5-day change 1-year change 3-year change Capi.($)
-6.47%-3.67%-96.67%-95.02% 805K
+0.27%+5.60%+27.17%+18.20% 232B
+1.36%+7.34%+3.52%-12.95% 152B
+1.16%-5.60%-21.16%+32.47% 132B
+2.03%-2.55%-52.50%+0.36% 71.55B
-0.04%-2.99%+10.32%+17.25% 51.78B
+0.98%+2.97%-16.53%-11.67% 51.75B
+1.73%+6.50%+33.49%+33.33% 44.14B
+1.49%-0.68%+38.41%+52.11% 39.76B
+1.03%+1.40%+1.29%+9.45% 33.45B
Average +0.35%-0.11%-7.27%+4.35% 80.85B
Weighted average by Cap. +0.97%+1.38%+3.73%+13.27%

Financials

2024 2025
Net sales 11.05M 1.17M 999K 935K 856K 1.61M 112M 1.63M 4.31M 56.06M 4.38M 4.29M 187M 3.04M 321K 275K 257K 236K 442K 30.75M 448K 1.19M 15.43M 1.21M 1.18M 51.47M
Net income -5.15M -544K -466K -436K -399K -749K -52.05M -759K -2.01M -26.12M -2.04M -2M -87.12M -10.16M -1.07M -919K -860K -787K -1.48M -103M -1.5M -3.96M -51.56M -4.03M -3.94M -172M
Net Debt -4M -423K -362K -339K -310K -582K -40.48M -590K -1.56M -20.32M -1.59M -1.55M -67.76M -2.83M -299K -256K -240K -219K -412K -28.63M -417K -1.1M -14.37M -1.12M -1.1M -47.92M
Logo Inhalation Sciences Sweden AB
Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Company’s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Company’s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Company’s main shareholder is Nordnet Pensionsforsakring.
Employees
5
Date Price Change Volume
26-08-21 SEK 0.1445 -6.47% 16,035
26-08-20 SEK 0.1545 +3.69% 11,458
26-08-19 SEK 0.1490 0.00% 50
26-08-18 SEK 0.1490 -2.30% 46,711
26-08-17 SEK 0.1525 +8.93% 98,093

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISAB Stock